Lung Cancer

Top Story

CIMAvax-nivolumab combination appears safe, demonstrates ‘good signals’ in advanced lung cancer

CIMAvax-nivolumab combination appears safe, demonstrates ‘good signals’ in advanced lung cancer
January 18, 2019
Feature

Corticosteroids, IV antibiotics increase risk for chemotherapy-induced febrile neutropenia

January 17, 2019
Use of corticosteroids, certain dermatologic or mucosal conditions, and antibiotics all appeared to increase risk for chemotherapy-induced febrile neutropenia among a…
In the Journals Plus

Treatment at academic centers yields survival benefit in metastatic NSCLC

January 15, 2019
Patients with metastatic non-small cell lung cancer who received treatment at academic…
In the JournalsPerspective

‘Remarkably low’ uptake of shared decision-making visits for lung cancer screening

January 15, 2019
Participation in shared decision-making visits before low-dose CT screening for lung cancer was “remarkably low” among Medicare enrollees, according to…
More Headlines »
CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »
Resource Centers
Discoveries from ASCO Lung Cancer

Discoveries from ASCO Lung Cancer

CME

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung…
More »